U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Drug Evaluation and Research (CDER)
  5. CDER Offices and Divisions
  6. Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine (ORPURM)
  1. CDER Offices and Divisions

Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine (ORPURM)

The Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine (ORPURM) consists of four review divisions: The Division of Pediatrics and Maternal Health (DPMH), the Division of Rare Diseases and Medical Genetics (DRDMG), the Division of Urology, Obstetrics and Gynecology (DUOG), and the Division of Pharmacology-Toxicology for Rare Diseases, Pediatrics, Urologic and Reproductive Medicine/Specialty Medicine (DPT-RPURM/SM). The Immediate office oversees the development, review, and regulation of applications for drug and biologic products reviewed in these divisions.

Contact Us

Mailing Address:

Food and Drug Administration
Center for Drug Evaluation and Research
Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine
10903 New Hampshire Avenue
Silver Spring, MD 20993
Main Line: 301-796-2200   
Fax: 301-796-9744 

Office and Division Contact Information (PDF - 77KB)

Resources



Back to Top